Release of hemoglobin from mechanically stressed erythrocytes into plasma is a general side effect of extracorporeal therapies, like extracorporeal membrane oxygenation and hemodialysis.
Dialysis patients often show elevated cell-free plasma hemoglobin levels due to repeated mechanical impact of erythrocytes. Cell-free plasma hemoglobin reacts with nitrogen oxide, which plays a role in cardiovascular signaling, and reduces its bioavailability. The purpose of this study was to measure cell-free plasma hemoglobin clearance of conventional high-flux dialysis filters, high-flux filters with extended permeability and high cut-off dialyzers and to evaluate the opportunity of reducing cell-free plasma hemoglobin levels. 
HEMOGLOBIN REMOVAL BY DIALYZERS OF DIFFERENT PERMEABILITY PROFILES

Methods
Polyflux Highflux 170H (Gambro), FX CorDiax 80 (Fresenius) and four different MCO high-flux dialyzers with extended permeability (Gambro) were tested on AK 200 Ultra with QB 400, QD 500 ml/min and UF 0 ml/min. In each experiment 1 L of bovine blood was spiked with about 1 g hemoglobin and dialysis treatments were simulated in a recirculating blood loop. Plasma samples were collected from the blood pool after defined intervals. Changes in cell-free plasma hemoglobin levels were measured photometrically at 405 nm detecting the heme-characteristic soret absorption band.
Clearance was calculated from the first order kinetics for the variation of hemoglobin. In the analogous way septeX-Sets (Gambro) were tested on a Prismaflex monitor with QB 200 ml/min, QD 2.5 l/h (42 ml/min) and UF 0 ml/min.
In a second set of experiments hemoglobin clearances were measured on the AK 200 Ultra with QB400, QD 700 and UF 0 ml/min in bovine plasma and a recirculation phase of 60 min with closed dialysate compartment prior to the dialysis treatment simulation. Hemoglobin was added after 55 min. 
